AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.564
-0.016 (-2.83%)
Nov 20, 2024, 4:00 PM EST - Market closed
AEON Biopharma Market Cap
AEON Biopharma has a market cap or net worth of $22.27 million as of November 21, 2024. Its market cap has decreased by -87.19% in one year.
Market Cap
22.27M
Enterprise Value
33.52M
1-Year Change
-87.19%
Ranking
Category
Stock Price
$0.56
Market Cap Chart
Since April 12, 2021, AEON Biopharma's market cap has decreased from $63.66M to $22.27M, a decrease of -65.01%. That is a compound annual growth rate of -25.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 22.92M | -91.43% |
| Dec 29, 2023 | 267.55M | -80.82% |
| Dec 30, 2022 | 1.40B | 553.24% |
| Dec 30, 2021 | 213.58M | 235.51% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlycoMimetics | 24.45M |
| Inspira Technologies Oxy B.H.N. | 23.68M |
| Chemomab Therapeutics | 23.26M |
| CytoMed Therapeutics | 23.19M |
| MIRA Pharmaceuticals | 23.19M |
| Tempest Therapeutics | 22.98M |
| IN8bio | 22.98M |
| Neuronetics | 22.92M |